Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas
Pancreatic ductal adenocarcinoma (PDAC) is reported to be amongst the cancers with the lowest survival rate at 5 years. In the present study we aimed to validate a targeted next-generation sequencing (tNGS) panel to use in clinical routine, investigating genes important for PDAC diagnostic, prognost...
Shranjeno v:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
Elsevier,
2024-10-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |